Oncotarget Positive News Article

What you need to know about Oncotarget Online Journal

Oncotarget is an online journal that was started by Impact Journals in 2010. Since its inception, the journal has been covering research on all aspects of oncology. Based on its popularity, the journal was ranked among the top 50 online journals in the United States in 2015 by Scimago Journal and Country Rank (SJR). Oncotarget is currently among the most popular online platforms that offer free access to a wide range of learning resources on oncology.

The site provides a weekly issue of online materials. Its rapidly increasing popularity has been attributed to the nature of its online resources. The platform provides insightful, constructive, punctual, and multiple peer-reviewed content on the fields of oncology and other scientific fields. The wide range of info has helped their subscribers, many of whom have a wide interest in research, to increase the impact of their research. Oncotarget is also the proud sponsor of the Gordon Research Conference. Visit his profile on Google Scholar.

The benefits that accrue to those seeking online resources on Oncotarget are as outlined below:

 Free access: Information from the online journal is open to anybody who wishes to access it. This saves you a significant amount of money that could have been used to pay for online subscriptions on other sites.

 Weekly updates: The journal is published on a weekly basis hence ensures that the information they provide is up to date and cannot be compared to other sites who update online resources after every three months.

 Provides papers beyond oncology: The Oncotarget’s scope has been widened to provide a wide range of information beyond oncology in areas such as neuroscience, endocrinology, metabolism, cell biology, pharmacology, and other scientific fields. Download output styles at Endnote.com

 Through the guidance of the most prominent scientists in the biomedical field, the journal provides an opportunity for all researchers to contribute to the progress of science. This is made possible by ensuring a rapid dissemination of new findings, elimination of barriers between specialities, and fostering the application of basic and clinical science to fight diseases.